drugset / Trial / NCT01368445
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
RandomizedFactorialTriple-blindTreatment
Summary
The Purpose of this study is to evaluate the safety and efficacy of MP03-36 (0.15% azelastine hydrochloride)at dosages of 2 sprays per nostril once daily and 2 sprays per nostril twice daily in patients with seasonal allergic rhinitis.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-11
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azelastine | Small molecule | 822 ug | Intranasal |
| Comparator | Azelastine | Small molecule | 1096 ug | Intranasal |
| Comparator | Azelastine | Small molecule | 1644 ug | Intranasal |